Circulating matrix metalloproteinases in adolescents with hypertrophic cardiomyopathy and ventricular arrhythmia.

Authors

Justin P. Zachariah, Children's National Medical Center
Steven D. Colan, Children's National Medical Center
Peter Lang, Children's National Medical Center
John K. Triedman, Children's Hospital Boston, Harvard Medical School, Boston, MA
Mark E. Alexander, Harvard Medical School,
Edward P. Walsh, Harvard Medical School,Follow
Charles I. Berul, George Washington UniversityFollow
Frank Cecchin, Harvard Medical School,

Document Type

Journal Article

Publication Date

7-2012

Journal

Circulation: Heart Failure

Volume

Volume 5, Issue 4

Inclusive Pages

462-466

Keywords

Cardiomyopathy; Hypertrophic--enzymology; Matrix Metalloproteinase 3--blood; Myocardium--enzymology; Tachycardia; Ventricular--enzymology; Ventricular Fibrillation--enzymology

Comments

This is a PubMed Central article. Click on link for full-text access.

APA Citation

Zachariah, J. P., Colan, S. D., Lang, P., Triedman, J. K., Alexander, M. E., Walsh, E. P., . . . Cecchin, F. (2012). Circulating matrix metalloproteinases in adolescents with hypertrophic cardiomyopathy and ventricular arrhythmia. Circulation: Heart Failure, 5(4), 462-466.

Peer Reviewed

1

Open Access

1